Indication
systemic inflammatory response syndrome
1 clinical trial
2 products
Clinical trial
A Randomized Clinical Trial of Oral Clarithromycin in Community-acquired Pneumonia to Attenuate Inflammatory Responses and Improve Outcomes: the ACCESS Clinical TrialStatus: Completed, Estimated PCD: 2023-04-11
Product
TabletsProduct
Clarithromycin